发明名称 |
Specific activation of a regulatory T cell and its use for treatment of asthma, allergic disease, autoimmune disease, graft rejection and for tolerance induction |
摘要 |
The present invention relates to a Treg cell activator for regulatory (Treg) cell activation via interaction with a Treg cell epitope as set forth in SEQ ID NO:1 which is HIV-1 gp120, or HIV-1 gp120 derived fragments, peptides or polypeptides thereof comprising an amino acid sequence as set forth in SEQ ID NO.: 3, SEQ ID NO.: 4, SEQ ID NO.: 5, SEQ ID NO.: 6, SEQ ID NO.: 7, SEQ ID NO.: 8, SEQ ID NO.: 9, or SEQ ID NO.: 10
for use in a method for the prevention or treatment of a disease, which is characterized in that its clinical picture is influenced positively by an increase of activated Treg cells in response to the Treg cell activator. |
申请公布号 |
EP2109770(A2) |
申请公布日期 |
2009.10.21 |
申请号 |
EP20080708459 |
申请日期 |
2008.01.30 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
SCHNEIDER, FRANZ-JOSEF;BECKER, CHRISTIAN;BOPP, TOBIAS;JONULEIT, HELMUT;SCHMITT, EDGAR |
分类号 |
G01N33/50;C07K14/005;C07K16/18 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|